Blue Heron Capital

360 Capital is an Early Stage European VC investing from Pre-Seed to Series A. We have offices in Paris 🇫🇷 & Milan 🇮🇹 and have €450M AUM. For more than two decades, we have been fortunate to back exceptional founders on their path to create globally impactful businesses such as Exotec, Preligens, Regate, Tiller Systems, Casavo, Heroes, Beanstock, Tediber, 900.care... We invest in businesses across Europe, with a focus on B2B process automation, Deep Tech and Mass Consumer Disruption.

InVitro Capital is a venture studio that creates, builds, and exits companies in the AI and B2B space. With a primary focus on Healthcare and SaaS, Invitro has developed a unique recipe to de-risk startup innovation and help aspiring exceptional entrepreneurs identify and capitalize on promising opportunities. At InVitro, we believe that the best startups are built by teams with deep domain expertise and a passion for solving real-world problems. That's why we invest in and partner with entrepreneurs who have a proven track record of success and a vision for the future. We provide our portfolio companies with the operational muscles and support they need to succeed, including: Seed funding. Access to our network of mentors and advisors. Expertise in tech, marketing, sales, and business development. Help with go-to-market strategy. We also have a unique approach to exits. Instead of waiting for a large tech company to come knocking, we actively work with our portfolio companies to develop and execute their own exit strategies. This allows us to maximize returns for our investors and give our entrepreneurs the freedom to pursue their next big idea

We help entrepreneurs succeed. It has been our mission from day one. We challenge existing paradigms of how things are done in the normal VC world. Our experience of actually being in the thick of the action day in, day out with Founders and their companies, actively pushing them towards their end game - wherever it might be - has taught us it pays off. To be active. To be present. To be hands on. To apply everything we know in every interaction, every task. Whatever it takes. We believe in People. Great people. They have been the center of attention since we started investing intensively in 2018. We invest in people in everything we do: in problems affecting potentially millions of people on a global scale, in deeply committed and talented founder teams, and in the strength, experience and know-how of our team and its ability to help our founders and portfolio companies succeed on their journeys. It’s all about People We partner with the most talented entrepreneurs – bringing to the table industry know-how, relentless dedication and money to move startups fast forward. What we look for We back start-ups and founder teams when we’re sure that our operational skillset, experience, and network will bring an original vision to life. From pre-seed to venture to expansive growth with best-in-class founders at every stage of the journey. While we like to keep an open mind, and only invest in companies that improve people and businesses’ everyday lives, we don’t want to invest our time (or money) in companies working within industries or sectors, which we consider bad for people. Our industry focus may change from time to time depending on emerging macro-economic, socio-economic, and technological trends. But based on a combination of our experiences, current capabilities, and interesting megatrends we see in the market, we focus our investments within technology-driven companies and with a soft focus on Digital health and SaaS products. What do you invest in? We invest in people in everything that we do: In real life challenges affecting potentially millions of people and businesses on a global scale and in deeply committed and talented founder teams of people uniquely qualified and motivated to grasp the problem and build tomorrows most powerful solutions. Tech companies, with software driven business-models. At our core we remain agnostic of what industries, we could potentially make investments in. Having said that there will be industries, where we will not be investing. While we like to keep an open mind, we also see the value in focusing our attention on a few, more specific industries. We are currently focused on digital health and enterprise software (B2B SaaS).

Andra’s team has helped accelerate the technological evolution of the world we live in by investing in the future. We support the growth of some of the most promising global companies to shape a brighter future. 30+ years of Silicon Valley technology investments and operational leadership experience* $100B+ Andra’s investments in technology and enterprise software companies representing $100B+ in value 140+ transactions with technology industry leaders* *Figures reflect years of industry experience and transactions for Partners at prior firms. Investors, Technologists, Operators, Entrepreneurs Our team brings deep domain expertise, extensive operational experience, decades of investment experience, financial markets sophistication, and a strong network of relationships The Andra AdvantageSeasoned Silicon Valley Investors: 30+ years of experience investing in technology companies across multiple stages of a company's lifecycle Operational Experience: 20+ years of experience founding and scaling technology unicorns and driving companies to exits Strategic Ecosystem: Global investor network that helps portfolio companies fuel growth through strategic partnerships Track Record: Proven track record of deal execution, value creation and investment expertise Investment Philosophy We strive to achieve superior and consistent returns by funding exceptional companies identified through our five core investment principles: Execute our powerful and unique investment thesis and process for each fund strategy that allows us to effectively identify and evaluate investment targets Select disruptive companies with enduring technology moats and strong business models that can scale efficiently irrespective of macroeconomic cycles Maintain valuation discipline, investing at levels that fit our risk parameters and returns profile Perform strong fundamental research bottom up research and documentation of every investment using our proprietary methodology Employ a portfolio approach to mitigate risk through sector and time diversification Investment StrategiesLate Stage Open-end fund focused on leading, pre-IPO technology companies with an exit horizon of 2-3 years. Target Company CharacteristicsTechnology category leaders in large and fast-growing markets Sustainable and scalable unit economics with a clear path to profitability Seeking capital to fuel growth and establish market dominance prior to an exit event Technologically differentiated business models that can create defensible moats Growth-Stage Closed-end fund focused on leading, disruptive, fast-growing private technology companies with an exit horizon of 5-8 years. Target Company CharacteristicsEmerging technology leaders in large markets ripe for disruption Proven product-market fit with scalable and viable unit economics Entering the hyper-growth phase of scaling their business Technologically differentiated business models that can create defensible moats Target VerticalsArtificial intelligence Data and analytics Cloud infrastructure Networking Cybersecurity FinTech Consumer Software B2B and B2C marketplaces Digital health

We are the Swanlaab’s first establishment in the United States and are backed up by an Israeli venture capital group, Giza Venture Capital (Giza VC) and Swanlaab Spain. With more than 25 years of investing experience, they have made more than 120 investments and achieved more than 40 successful exits. Since 1992, Swanlaab and Giza have managed six funds and invested over $650 million. Thanks to its expertise and experienced team, Giza Venture Capital Group has become one of the leading VC groups and has led to numerous successful exits. Some of the winning investments include: XtremIO (acquired by EMC for $435M), Soluto (acquired by Asurion for $100M+), Oplus (acquired by Intel for $100M+), Actimize (acquired by NICE Systems for $281M), Precise (IPO on NASDAQ; acquired by Veritas), Zoran (IPO on NASDAQ; acquired by CSR), M-Systems (IPO on NASDAQ; acquired by SanDisk). Innovation and Technology We invest in globally competitive startups who have strong innovations in their technologies, that provide high barriers to entry, and are focused on B2B business models. Our H3IT (healthcare, information technology, Internet, and impact investment) strategy is clear and sets us apart in the market. All in all, Swanlaab USA has everything for smart investors to maximize shareholder value. integrity great pedigree, history, and background team business model ready for long term value acceleration sustainable competitive advantages for multiple bottom lines

Crew Capital was co-founded by Brandon Deer & Daniel Dines, both officers at UiPath. The firm's unique strategy is driven by active operator GP's, and combines the flexibility of angel-style investing with institutional-grade resources for founders. With a presence in Miami, New York, and Europe, the firm is backing leading companies across B2B software, fintech, digital health, e-commerce, and tech-enabled services.